Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Cerebral Toxoplasmosis in a Patient with Prolonged CD4 Lymphopenia Post Autologous Haematopoietic Stem Cell Transplant

Arielle van Mourik, MBBS BBiomedSci, Andrew P Grigg, MBBS MD

Blood (2016) 128 (22): 4902.

https://doi.org/10.1182/blood.V128.22.4902.4902

Published: 2016

Journal Articles

Post-Transplant Cyclophosphamide and Bortezomib Combination for Prevention of GvHD after Allogeneic Blood and Marrow Transplantation Is Feasible and Produces Favorable Outcomes

A. Samer Al-Homsi, MD, Tara S Roy, NP, Kelli Cole, RN, MSN, Marlee Bogema, RN, BSN, Stephanie F Williams, MD, Ulrich A. Duffner, MD, Aly Mageed, MD

Blood (2014) 124 (21): 3920.

https://doi.org/10.1182/blood.V124.21.3920.3920

Published: 2014

Journal Articles

HLA-Matched Related Donor Hematopoietic Cell Transplantation in Patients with Fanconi Anemia Conditioned with a Combination of Cyclophosphamide and Fludarabine : A Study on Behalf of the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)

Lina Benajiba, MD, Clementine Salvado, MD, Jean-Hugues Dalle, MD PhD, Charlotte Jubert, MD, Claire Galambrun, MD, Jean Soulier, MD PhD, Gerard Socie, MD PhD, Regis Peffault de Latour, MD PhD

Blood (2014) 124 (21): 4391.

https://doi.org/10.1182/blood.V124.21.4391.4391

Published: 2014

Journal Articles

Outcome Of Bone Marrow Transplantation In Lebanese Children With β-Thalassemia Major

Adlette Inati, MD, Javid Gaziev, MD, Hussein A Abbas, PhD, Serge Korjian, BSc, Yazan Daaboul, BSc, Mario Kahale, MD, Katia Paciaroni, MD, Gioia de Angelis, MD, Ali T Taher, MD, Therese Abi Nasr, MD, Suzan Koussa, MD, Guido Lucarelli, MD

Blood (2013) 122 (21): 5505.

https://doi.org/10.1182/blood.V122.21.5505.5505

Published: 2013

Journal Articles

Combination of Ofatumumab and Lenalidomide in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): Results of a Phase II Trial

Alessandra Ferrajoli, M.D., Lorenzo Falchi, MD, Susan O'Brien, MD, William Wierda, MD, PhD, Stefan Faderl, MD, Susan C. Smith, BS, Ana B. Ayala, ADN, Hagop M. Kantarjian, MD, Michael J. Keating, MD

Blood (2012) 120 (21): 720.

https://doi.org/10.1182/blood.V120.21.720.720

Published: 2012

Journal Articles

Combination Therapy with Ofatumumab and Lenalidomide in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): Results of a Phase II Trial

Alessandra Ferrajoli, MD, Susan O'Brien, MD, William G. Wierda, MD, PhD, Stefan Faderl, MD, Xavier Badoux, MD, Zeev Estrov, Ellen Schlette, MD, Susan C. Smith, BS, Ana B. Ayala, ADN, Lorenzo Falchi, MD, Steliana Calin, MD, Hagop M. Kantarjian, MD, Michael J Keating, MD

Blood (2011) 118 (21): 1788.

https://doi.org/10.1182/blood.V118.21.1788.1788

Published: 2011

Journal Articles

Near-Tetraploidy in Childhood Acute Lymphoblastic Leukemias Does Not Adversely Affect Prognosis: An EGIL Retrospective Study On 36 Cases Petr Lemez, Andishe Attarbaschi, Marie-Christine Bene, Yves Bertrand, Gian-Luigi Castoldi, Erik Forestier, Richard Garand, Oskar A. Haas, Emmanuelle Homolle, Sandrine Kagialis-Girard, Wolf-Dieter Ludwig, Estella Matutes, Marie-Pierre Pages, Winfried Pickl, Anna Porwit, Alberto Orfao, Jan Stary, Herbert Strobl, Pascaline Talmant, Mars B. Van't Veer, Zuzana Zemanova, for the European Group for the Immunological Characterization of Leukaemias (EGIL). (Introduced by Jaroslav Jelinek) Dept. of Hematology, Hosp. Jihlava, Jihlava, Czech Rep .

Petr Lemez

Blood (2009) 114 (22): 1585.

https://doi.org/10.1182/blood.V114.22.1585.1585

Published: 2009

Journal Articles

VEBEP Regimen and Highly Active Antiretroviral Therapy (HAART) in Patients (pts) with HD and HIV Infection (HD-HIV): Final Results of the Italian Cooperative Group on AIDS and Tumors (GICAT) Study.

Michele Spina, MD, Andrea Antinori, Valentina Neri, Giuseppe Rossi, Alessandro Re, Bernardino Allione, Emanuela Chimienti, Renato Talamini, Umberto Tirelli

Blood (2008) 112 (11): 1466.

https://doi.org/10.1182/blood.V112.11.1466.1466

Published: 2008

Journal Articles

Results of the Largest Study on Post-Transplant-Lymphoproliferations (PTLDs) of the Central Nervous System (CNS) in the Rituximab Era: A Surprising Overrepresentation of Kidney Transplantations, Key Importance of Methotrexate (Mtx), Cytarabine (AraC) and Radiotherapy (RX) for Long Term Survival and Low Impact of Rituximab (R)

Sylvain Choquet, Stefan Oertel, Ioannis Anagnostopoulos, Hanno Riess, Madalina Uzunov, V.éronique Leblond, Ralf Trappe

Blood (2008) 112 (11): 3614.

https://doi.org/10.1182/blood.V112.11.3614.3614

Published: 2008

Journal Articles

Combination of Transplantation of Haploidentical Human Mesenchymal Stem Cells and Rituximab Therapy in a Patient with Extensive Therapy-Refractory Chronic Graft Versus Host Disease.

L. Mueller, M. Christopeit, J. Luetzkendorf, K. Reichelt, E. Schlesinger, M. Schulze, G. Behre

Blood (2006) 108 (11): 5290.

https://doi.org/10.1182/blood.V108.11.5290.5290

Published: 2006

Journal Articles

Induction with Fludarabine, Cyclophosphamide and Rituximab Followed by Maintenance with Rituximab: Results of a Prospective Study in 75 Patients (LNHF-03).

Jose F. Tomas, MD, PhD, Carlos Montalban, Joaquin Martinez-Lopez, Jose Paz, Miguel Canales, Joaquin Diaz-Mediavilla, Pedro Sanchez Godoy, Alberto Fdez de Sevilla, Javier Penalver, MDolores Caballero, Elena Prieto, Jose Salar, Raquel de Ona, Javier de la Serna

Blood (2006) 108 (11): 2762.

https://doi.org/10.1182/blood.V108.11.2762.2762

Published: 2006

Journal Articles

Post-Engraftment Infections in Adult Patients Transplanted with Single Cord Blood Units Supported by Co-Infusion of Mobilized Purified Hematopoietic Stem Cells from a Third Party Donor.

J. Rafael Cabrera, Isabel Krsnik, Rafael Fores, Elena Ruiz, Guiomar Bautista, Belen Navarro, Jorge Gayoso, Santiago Gil, Carmen Regidor, Isabel Sanjuan, Emilio Ojeda, Jose A. Garcia-Marco, Manuel N. Fernandez

Blood (2005) 106 (11): 3240.

https://doi.org/10.1182/blood.V106.11.3240.3240

Published: 2005

Journal Articles

VEBEP Regimen and Highly Active Antiretroviral Therapy (HAART) in Patients (pts) with HD and HIV Infection (HD-HIV).

Michele Spina, MD, Giuseppe Rossi, MD, Andrea Antinori, MD, Bernardino Allione, MD, Marco Fasan, MD, Giuliano Rizzardini, MD, Umberto Tirelli, MD

Blood (2005) 106 (11): 329.

https://doi.org/10.1182/blood.V106.11.329.329

Published: 2005

Journal Articles

Low Progression-Free Survival for High-Risk Patients Treated with Reduced-Intensity Conditioning Regimen Allogeneic Stem Cell Transplantations with Volunteer Unrelated Donors.

Reza Tabrizi, MD, Fontanet Bijou, MD, Krimo Bouabdallah, MD, Thibaut Leguay, MD, Gerald Marit, MD, Arnaud Pigneux, MD, Aurelie Gomez, MD, Francis Belloc, Xavier Lafarge, Jean-Michel Boiron, MD, PhD

Blood (2005) 106 (11): 5432.

https://doi.org/10.1182/blood.V106.11.5432.5432

Published: 2005

NARROW

Cerebral Toxoplasmosis in a Patient with Prolonged CD4 Lymphopenia Post Autologous Haematopoietic Stem Cell Transplant

Post-Transplant Cyclophosphamide and Bortezomib Combination for Prevention of GvHD after Allogeneic Blood and Marrow Transplantation Is Feasible and Produces Favorable Outcomes

HLA-Matched Related Donor Hematopoietic Cell Transplantation in Patients with Fanconi Anemia Conditioned with a Combination of Cyclophosphamide and Fludarabine : A Study on Behalf of the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)

Outcome Of Bone Marrow Transplantation In Lebanese Children With β-Thalassemia Major

Combination of Ofatumumab and Lenalidomide in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): Results of a Phase II Trial

Combination Therapy with Ofatumumab and Lenalidomide in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): Results of a Phase II Trial

VEBEP Regimen and Highly Active Antiretroviral Therapy (HAART) in Patients (pts) with HD and HIV Infection (HD-HIV): Final Results of the Italian Cooperative Group on AIDS and Tumors (GICAT) Study.

Combination of Transplantation of Haploidentical Human Mesenchymal Stem Cells and Rituximab Therapy in a Patient with Extensive Therapy-Refractory Chronic Graft Versus Host Disease.

Induction with Fludarabine, Cyclophosphamide and Rituximab Followed by Maintenance with Rituximab: Results of a Prospective Study in 75 Patients (LNHF-03).

Post-Engraftment Infections in Adult Patients Transplanted with Single Cord Blood Units Supported by Co-Infusion of Mobilized Purified Hematopoietic Stem Cells from a Third Party Donor.

VEBEP Regimen and Highly Active Antiretroviral Therapy (HAART) in Patients (pts) with HD and HIV Infection (HD-HIV).

Low Progression-Free Survival for High-Risk Patients Treated with Reduced-Intensity Conditioning Regimen Allogeneic Stem Cell Transplantations with Volunteer Unrelated Donors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only